Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Registration Statement No. 333-289703 on Form F-1, as amended, of our report dated March 31, 2026, relating to the consolidated financial statements of Galmed Pharmaceuticals Ltd. (the “Company”), appearing in the Company’s Annual Report on Form 20-F for the year ended December 31, 2025. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

 

/s/ Brightman Almagor Zohar & Co.  
Brightman Almagor Zohar & Co  
Certified Public Accounts  
A Firm in the Deloitte Global Network  
   
Tel Aviv, Israel  
March 31, 2026